Atrium Medical Center
Atrium Medical Center has served Southwest Ohio from its Middletown campus since 1917. We offer a wide range of advanced, innovative care from our 260-acre campus. Leading national organizations regularly recognize our quality care. We are Warren County's only Level III Trauma Center and Primary Stroke Center, providing immediate assessment and care for seriously injured or ill patients, and the only accredited Chest Pain Center in Warren County. We offer maternity, cancer, orthopedics, and heart care, and much more. Atrium Medical Center was named among America's 100 Best Hospitals by Healthgrades.
Location Information
Patients
Welcome! We want to make your hospital stay as comfortable and easy as possible. Learn what to expect before, during, and after your inpatient stay or outpatient visit.
Pricing, billing, and insurance >
Medical records >
Patient registration >
Patient scheduling >
About your hospital stay >
Visitors
Whether you’re a patient, family member, friend, or business partner, we welcome you to our campus. Get more information on parking, how to contact patients, rules for visiting patients, and the amenities we offer, including our food and dining options.
Our Providers
Whether you’re looking for a primary care provider or a specialist, our physicians and advanced practice providers offer you advanced, compassionate care in a wide range of specialties. You’ll find them conveniently close to home and work.
See all providers
Awards
We’re proud to make a difference in our community. When others recognize our achievements, we know we’re fulfilling our mission. We’re grateful for the awards and recognition our hospital and people have earned.
See all awardsUpcoming Events
Thursday, August 1, 2024
Mobile Mammography
A mammogram is the best way to detect breast cancer early
9:00 AM - 4:00 PM
Schulte Wellness
1928 Donn Davis Way
Tipp City, OH 45371
Saturday, August 3, 2024
Mobile Mammography
A mammogram is the best way to detect breast cancer early
11:00 AM - 4:00 PM
Restoration Church
904 Vernon Drive
Dayton, OH 45405
Friday, August 9, 2024
Mobile Mammography
A mammogram is the best way to detect breast cancer early
9:00 AM - 5:00 PM
Monroe Medical Center
35 Overbrook Drive
Monroe, OH 45050
Latest News
Premier Health to Offer New Antibody Therapy to COVID-19 Patients
Bamlanivimab Shown in Clinical Trials to Reduce Hospitalizations From Virus
DAYTON, Ohio (December 2, 2020) – Premier Health is offering a new antibody therapy for those who have tested positive for COVID-19 and are at high risk for severe illness but who currently are experiencing mild to moderate symptoms.
Bamlanivimab received emergency use authorization from the Food & Drug Administration earlier this month. While the investigational therapy’s safety and effectiveness continue to be evaluated, the therapy has been shown in clinical trials to reduce COVID-19 related hospitalizations or emergency room visits in patients at high risk for disease progression within 28 days of treatment, according to its manufacturer, Eli Lilly.
Premier Health has begun offering the therapy at select ambulatory locations. This medication is not available for hospitalized patients, and its availability will be limited initially. A referral from a primary care or emergency care provider is required.
“This experimental treatment joins others such as convalescent plasma therapy and Regeneron’s antibody treatment as potential ways to help those who have contracted COVID-19,” said Dr. Roberto Colón, MD, system vice president of quality and safety for Premier Health and associate chief medical officer at Miami Valley Hospital. “The monoclonal antibodies are basically lab-produced proteins that mimic that body’s immune response and help fight off the virus. The reduction in hospitalizations associated with investigational use of this therapy are encouraging to see, but Bamlanivimab remains in limited supply.”
Eligible patients must have just received their first positive result for the virus, with the onset of symptoms within the past seven days. As a result, the window of opportunity to be treated with Bamlanivimab is limited, as the body generally has begun generating its own antibodies after several days of symptoms, rendering the drug less effective.
In addition, patients must have at least one factor that places them at higher risk for severe illness or hospitalization, including being age 65 or older and meeting certain criteria for chronic health disease.
Bamlanivimab is still being studied, and all possible side effects might not yet be known. Some potential side effects could include allergic reactions. Bamlanivimab could also interfere with the body’s ability to fight off a future COVID-19 infection and could reduce the body’s immune response to a COVID-19 vaccine, according to Eli Lilly.
*The current wait time is an estimated wait time before a person sees a physician and is not a guarantee. It is based on patient activity (how many patients are being treated and the severity of their injuries) within the last hour, and it is subject to change at any moment. If you are experiencing an emergency, call 911.